The $31 central target reflects six current, individually attributable analyst price targets reviewed for this analysis, not a single firm's view. The targets are: Piper Sandler at $27 (Overweight, November 2026, lowered from $29), Roth MKM at $30 (Buy, analyst Craig Irwin, November 2026), H.C. Wainwright at $42 (Buy, analyst Amit Dayal, November 2026), Northland Securities at $30 (Buy, initiation, October 2026), Needham at $22 (Buy, lowered from $40 after Q3 results), and ThinkEquity at $35 (Buy, analyst Ashok Kumar).
The spread is unusually wide. The low of $22 sits roughly 86% above the current price, while the high of $42 sits more than 250% above it. The gap reflects divergent assumptions about how quickly UMAC can convert rapid revenue growth into profitability and about the durability of its defense and commercial demand. Notably, several firms cut their targets after the November 2026 earnings report — Piper Sandler trimmed to $27, Roth MKM to $30, and Needham to $22 from $40 — a sign that analysts are tempering near-term expectations even while most retain Buy or Overweight ratings. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
As of the most recent verified close, UMAC traded near $11.83, with a market capitalization of roughly $614 million. The stock is well off its 52-week high of $34.93 reached in August 2026, and it sits below both its 50-day and 200-day moving averages. A move to $31 would require an advance of about 162%, which is a very large gap that would likely need a sustained, multi-quarter re-rating rather than a single catalyst.
The company's Q3 2026 results illustrate both the opportunity and the problem. Revenue rose roughly 551% year over year to about $13.9 million, and management pointed to a roughly $25 million revenue target for Q4, with demand still outpacing supply. But the net loss widened to about $25 million, and the trailing-twelve-month loss per share was around $0.76, meaning volume growth has not yet translated into earnings. From what I see, this gap between top-line growth and bottom-line results remains the core tension.
The durable reference points are stark. The 52-week high of $34.93 (August 2026) sits just above the $31 target, while the 52-week low of $7.25 (November 2025) reflects how far the stock has traveled in both directions. With shares trading in the low teens, the $31 target sits well above current price action and below the prior high, meaning any advance would need to clear multiple overhead zones where prior buyers may be sitting on losses. The stock trades below its 50-day moving average near $19.81 and its 200-day moving average near $19.02, indicating the longer-term trend has turned lower for now.
Analyst price targets generally reflect a research horizon of about 12 months, though firms differ in their assumptions and some targets were reset immediately after the November 2026 earnings report. Investors should watch upcoming quarterly results and guidance — particularly whether the company can sustain revenue growth while narrowing losses — as well as any changes to analyst targets, new defense or commercial contracts, production capacity announcements, and share-issuance activity. Given the stock's volatility and short interest, sentiment shifts can matter as much as fundamentals in the near term. I’m watching this closely as the next few quarters will likely clarify the trajectory.
For traders looking to track a fast-moving name like UMAC, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to fundamental research. The system uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover opportunities, monitor existing positions, and spot shifting trends more efficiently than scanning charts manually. In my view, this has become a useful part of my own routine for names with this level of movement.
The $31 central target for Unusual Machines is an average of six analyst price targets spanning $22 to $42, and it implies a very large move of roughly 162% from a price near $11.83. The bull case rests on exceptional revenue growth, a strategic position in domestic drone components, a cash-rich balance sheet, and long-term defense and commercial demand. The bear case rests on widening losses, heavy dilution, high short interest, and extreme volatility. With analysts disagreeing sharply on valuation and several firms lowering targets after the latest earnings report, the path to $31 depends above all on the company demonstrating a credible route from rapid growth to sustainable profitability. No outcome is guaranteed, and the target should be read as a research estimate rather than a forecast of near-term price action.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where UMAC declined for three days, in 152 of 172 cases, the price declined further within the following month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for UMAC turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 23 similar instances when the indicator turned negative. In 19 of the 23 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
The Aroon Indicator for UMAC entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UMAC's RSI Indicator exited the oversold zone, 9 of 9 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +25.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where UMAC advanced for three days, in 135 of 142 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
UMAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.532) is normal, around the industry mean (-6.197). UMAC has a moderately low P/E Ratio (-85.000) as compared to the industry average of (-3.670). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (26.954) is also within normal values, averaging (51.774).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. UMAC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UMAC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerProcessingHardware